Mylan Petitions For Review In Benicar Patent Dispute With U.S. Supreme Court
WASHINGTON, D.C. — In a drug patent infringement lawsuit over Apotex Inc.’s efforts to end Mylan Pharmaceuticals Inc.’s generic exclusivity for “Benicar” hypertension drug, Mylan in a Sept. 8 petition for...To view the full article, register now.
Already a subscriber? Click here to view full article